Bendicio, Kyle N.
HRN: 26-06-78 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2024
AMPICILLIN 250MG (VIAL)
10/26/2024
11/01/2024
IV
160
Q12
PSNB
Waiting Final Action
10/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/26/2024
11/01/2024
IV
35
Q24
PSNB
Waiting Final Action
01/04/2025
CEFUROXIME 750MG (VIAL)
01/04/2025
01/11/2025
IV
205 Mg
Q8h
Pcap C
Waiting Final Action